-
Gilead Sciences Recalls One Lot Of Its COVID-19 Treatment Due To Presence Of Glass Particles
Monday, September 23, 2024 - 2:12pm | 423Gilead Sciences Inc. (NASDAQ:GILD) has voluntarily recalled one lot of its COVID-19 treatment, Veklury (remdesivir), for Injection 100 mg/vial, after discovering glass particles in the vials. The company received a customer complaint that prompted an investigation, confirming the presence of...
-
No Legwork Mondays – Merck And Vioxx
Monday, April 14, 2014 - 9:45am | 499One of the clichés about the 21st century is that seniors are living longer, thanks to health care providers and drug makers. And like many clichés this saying has its roots in reality. Unfortunately, sometimes these purveyors of health have failed miserably. In the case of...